Accéder au contenu
Merck

A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.

Science (New York, N.Y.) (1999-10-16)
Y Q Tang, J Yuan, G Osapay, K Osapay, D Tran, C J Miller, A J Ouellette, M E Selsted
RÉSUMÉ

Analysis of rhesus macaque leukocytes disclosed the presence of an 18-residue macrocyclic, tridisulfide antibiotic peptide in granules of neutrophils and monocytes. The peptide, termed rhesus theta defensin-1 (RTD-1), is microbicidal for bacteria and fungi at low micromolar concentrations. Antibacterial activity of the cyclic peptide was threefold greater than that of an open-chain analog, and the cyclic conformation was required for antimicrobial activity in the presence of 150 millimolar sodium chloride. Biosynthesis of RTD-1 involves the head-to-tail ligation of two alpha-defensin-related nonapeptides, requiring the formation of two new peptide bonds. Thus, host defense cells possess mechanisms for synthesis and granular packaging of macrocyclic antibiotic peptides that are components of the phagocyte antimicrobial armamentarium.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Beta D-4 human, recombinant, expressed in E. coli, ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
NP-1 human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
Beta D-1 (36 aa) human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
Beta D-1 (47 aa) human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture